Literature DB >> 16770241

Predictive factors for anemia six and twelve months after orthotopic liver transplantation.

Joelle Guitard1, David Ribes, Nassim Kamar, Fabrice Muscari, Laurence Lavayssière, Bertrand Suc, Laure Esposito, Jean-Marie Perron, Lionel Rostaing.   

Abstract

BACKGROUND: The aim of our study was to determine the prevalence and predictive factors for post-transplant anemia (PTA) at 6 (M6) and 12 (M12) months after orthotopic liver-transplant (OLT) in a cohort of 97 consecutive patients.
METHODS: Anemia was defined at M6 and M12 according to the World Health Organization criteria, i.e., a hemoglobin level of <12 g/dL for women and <13 g/dL for men. Immunosuppression relied on tacrolimus and steroids with or without mycophenolate mofetil.
RESULTS: Anemia was present in 64.5%, 50%, and 52.8% of patients before OLT and at M6 and M12, respectively. Of the anemic patients, 33% (M6) and 30.3% (M12) received recombinant erythropoietin therapy. In multivariate analysis, the independent predictive factors for anemia at M6 were mean corpuscular volume (<85 fl) at day 7, daily steroid dosage (<0.3 mg/kg), serum creatinine (>130 micromol/L), and hemoglobin level (<11 g/dL) 1 month after OLT (M1). Independent predictive factors for anemia at M12 were daily steroid dosage at M1 (<0.3 mg/kg), hematocrit at M1 (<33%), red blood cell count at M6 (<3.75 T/L), daily dosage at M1 of cyclosporine and tacrolimus, and OLT for causes other than alcohol abuse.
CONCLUSION: Anemia is highly prevalent within the first year post-OLT. This deserves further investigation and appropriate treatment.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16770241     DOI: 10.1097/01.tp.0000209602.54351.a6

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  1 in total

1.  Risk factors for chronic anemia in pediatric orthotopic liver transplantation: analysis of data from the SPLIT registry.

Authors:  R I Liem; R Anand; W Yin; E M Alonso
Journal:  Pediatr Transplant       Date:  2011-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.